Search for: "Myers v. Good" Results 421 - 440 of 483
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Apr 2008, 9:00 am
No problem…: Lundbeck A/S v Generics UK Ltd & Ors: (IPKat), Exelon (Rivastigmine Tartrate) – Dr Reddy’s and Novartis settle Exelon patent dispute: (Therapeutics Daily), GeneMaker – Codon Devices, Blue Heron Biotechnology settle patent suit over gene synthesis platform: (Patent Docs), Glucophage (Metformin) – Depomed settles patent litigation against IVAX: (SmartBrief), (IP Law360), (GenericsWeb), Lexapro… [read post]
25 Jul 2023, 1:43 am by Matthieu Dhenne (Dhenne Avocats)
This being the case, the court notes that this WO’652 document reveals tests, resulting in the determination of “most preferred” compounds with very good affinity and in particular a Ki # 0.001 μM. [read post]
2 May 2008, 7:00 am
: Lupin v Abbott Labs: (FDA Law Blog), Plavix (Clopidogrel) – US: Apotex sues FDA to recover 180-day exclusivity on generic Plavix: (Orange Book Blog), Plavix (Clopidogrel) – US: Former Bristol-Myers Squibb executive charged over lying about Plavix deal struck with rival Apotex: (Managing Intellectual Property), Risperdal (Resperidone) – US: Apotex files motion to intervene in relisting of Risperdal patent case; Teva quickly files… [read post]
16 May 2008, 8:03 am
: (GenericsWeb), Europe: New EBA referral T 1319/04 regarding patentability of known medicament for new treatment of same illness: (IPKat), Europe: Patentability of biotechnology in Europe: (IAM), Europe: New EPO Enlarged Board case referrals: T1319/04 Dosage Regimen, T1242/06 Essential Biological Process: (Hal Wegner), Thailand: Compulsory licensing: Affordable health for Thailand thanks to Matrix Labs: (Spicy IP), Thailand: European Parliament set to reprimand Mandelson for… [read post]
19 Sep 2008, 6:00 pm
: (Ars Technica), Google, GE join forces for green tech research, lobbying: (Ars Technica), AIPPI Congress: how to protect you IP rights in virtual worlds (Managing Intellectual Property), Industry still wary of ICANN plan for new top-level internet domains: (Intellectual Property Watch), Ubuntu-Firefox EULA dustup reignites OSS licensing debate: (Ars Technica), Media standard backers attempt Apple-less solo run: (Out-Law), Open Source in Mobile conference: OpenMoko CEO says embrace fragmentation,… [read post]
As with a wide range of presidential obligations, the Chief Executive must therefore be given reasonable latitude to fulfill his duties in good faith and with a keen sense of the practical and feasible. [read post]
19 Dec 2011, 4:00 am by Terry Hart
The term refers to the fact of printing free from prior restraint, and not at all to the matter printed, whether good or bad. [read post]
16 Jan 2014, 4:30 am by Guest Blogger
Evidence Act) were legislated into hurried existence in the late 1960’s, in response to the decision in, Myers v. [read post]
3 Aug 2010, 3:17 pm by David Lat
— author of the colorful opinion in Gustafson v. [read post]
8 Apr 2024, 10:08 am by admin
Dwyer, a young, earnest immunologist who had done some contract work on an unrelated matter for Bristol-Myers Squibb, a defendant in the litigation. [read post]
11 Jun 2018, 2:54 pm by George Conway
The Supreme Court has never squarely addressed the point under the Appointments Clause, but in discussing presidential removal power in Myers v. [read post]